Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 8Phase 3 4Phase 1 4Phase 4 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 53Completed 50Recruiting 32Not yet recruiting 12Terminated 10Active not recruiting 9Withdrawn 4Suspended 1

Sponsor Class

INDUSTRY 102OTHER 87NETWORK 14OTHER_GOV 4NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Pathologic Complete Response 1Hepatitis C 1Carcinoma, Hepatocellular 1

Interventions

Carboplatin 2pertuzumab 1elbasvir-grazoprevir drug combination 1Trastuzumab 1Surgical Procedures, Operative 1Paclitaxel 1Magnesium 1Hydralazine 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Withdrawn × OTHER_GOV × Clear all
NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

National Institute of Cancerología

Phase 3 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Henan Cancer Hospital

Phase 3 Withdrawn
Breast

Pathologic Complete Response, Breast Neoplasms

NCT04546802 2020-09-14

HATCHeT

Bayside Health

Phase 3 Withdrawn
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT01906112 2015-02-27

Role of Surgery for the Primary in Patients With Breast Cancer Stage IV.

National Cancer Institute, Thailand

Phase 3 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡